Ca2+-dependent permeability transition and complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington's or Alzheimer's disease

被引：21
|
作者：
Panov, A [1 ]
Obertone, T [1 ]
Bennett-Desmelik, J [1 ]
Greenamyre, JT [1 ]
机构：
[1] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
来源：
OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS | 1999年 / 893卷
关键词：
D O I：
10.1111/j.1749-6632.1999.tb07856.x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：365 / 368
页数：4
相关论文
共 45 条
  • [31] Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's disease (vol 2, pg 294, 2015)
    Zhang, Liang
    Zhang, Song
    Maezawa, Izumi
    Trushin, Sergey
    Minhas, Paras
    Pinto, Matthew
    Jin, Lee-Way
    Prasain, Keshar
    Nguyen, Thi D. T.
    Yamazaki, Yu
    Kanekiyo, Takahisa
    Bu, Guojun
    Gateno, Benjamin
    Chang, Kyeong-Ok
    Nath, Karl A.
    Nemutlu, Emirhan
    Dzeja, Petras
    Pang, Yuan-Ping
    Hua, Duy H.
    Trushina, Eugenia
    EBIOMEDICINE, 2019, 42 : 532 - 532
  • [32] Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease)
    Khorshid, Hamid Reza Khorram
    Manoochehri, Mehdi
    Nasehi, Leila
    Ohadi, Mina
    Rahgozar, Mehdi
    Kamali, Koorosh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2012, 15 (04) : 937 - 944
  • [33] Intracellular Injection of Brain Extracts from Alzheimer's Disease Patients Triggers Unregulated Ca2+ Release from Intracellular Stores That Hinders Cellular Bioenergetics
    Pensalfini, Anna
    Umar, Abdul Rahim
    Glabe, Charles
    Parker, Ian
    Ullah, Ghanim
    Demuro, Angelo
    CELLS, 2022, 11 (22)
  • [34] Impaired apoptosis in lymphoblasts from Alzheimer’s disease patients: Cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways
    F. Bartolomé
    N. de las Cuevas
    Ú. Muñoz
    F. Bermejo
    Á. Martín-Requero
    Cellular and Molecular Life Sciences, 2007, 64 : 1437 - 1448
  • [35] Elevated [Ca2+]i Levels Occur with Decreased Calpain Activity in Aged Fibroblasts and Their Reversal by Energy-Rich Compounds: New Paradigm for Alzheimer's Disease Prevention
    Nguyen, Huey T.
    Sawmiller, Darrell R.
    Markov, Olga
    Chen, Ming
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 37 (04) : 835 - 848
  • [36] I-2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease
    GargalidisMoudanos, C
    Pizzinat, N
    JavoyAgid, F
    Remaury, A
    Parini, A
    NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (01) : 31 - 36
  • [37] Impaired apoptosis in lymphoblasts from Alzheimer's disease patients:: Cross-talk of Ca2+ stop/calmodulin and ERK1/2 signaling pathways
    Bartolome, F.
    de las Cuevas, N.
    Munoz, U.
    Bermejo, F.
    Martin-Requero, A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (11) : 1437 - 1448
  • [38] Downregulation of ERK1/2 activity by CaMKII modulates p21 levels and survival of immortalized lymphocytes from Alzheimer's disease patients
    Esteras, N.
    Alquezar, C.
    Martin-Requero, A.
    FEBS JOURNAL, 2012, 279 : 144 - 144
  • [39] LINKING ABNORMAL CA2+SIGNALING AND THE UNFOLDED PROTEIN RESPONSE WITH HUNTINGTON'S DISEASE PATHOLOGY IN BOTH IPSC- DERIVED MSNS NEURONS AND STRIATAL ORGANOIDS FROM HD PATIENTS
    Latoszek, Ewelina
    Egbuwalo, Samuel Oluwafemi
    Piechota, Marta
    Liszewska, Ewa
    Hansikova, Hana
    Klempir, Jiri
    Muehlbaeck, Alzbeta
    Landwehrmeyer, Georg Bernhard
    Kuznicki, Jacek
    Czeredys, Magdalena
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 1646 - 1647
  • [40] Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target
    Arosio, Beatrice
    Casati, Martina
    Gussago, Cristina
    Ferri, Evelyn
    Abbate, Carlo
    Scortichini, Valeria
    Colombo, Elena
    Rossi, Paolo Dionigi
    Mari, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (02) : 417 - 425
12345